ARCHIVES

In Brief: Hatch Bill Would Require NDA Sponsors To Pay Fee; IND, Generic Drug NDAs Would Be Exempt

This article is from The Cancer Letter archive.

Vol. 12 No. 34 | August 22, 1986

Download PDF Visit The Full Archive

Related Articles

Dileep Bal Elected Cancer Society President, Young Is President-Elect, Baity Leads Board.

December 8, 2000

FCRC Contract Will Be Completed In Five Parts, Two of Them For Small Business; RFP Available July 24

July 3, 1981

Chabner, FDA’s Temple continue disagreement Over Drug Approval

February 10, 1989

FDA Approves Arranon For Leukemia And Lymphoma

December 30, 2005

Lilly Begins Phase III Trial Of Alimta In Extensive SCLC

October 27, 2006

NCI-Approved CTEP Trials For the Month of September

September 28, 2012